Arvinas, Inc.
NASDAQ:ARVNBiotechnology
-$0.10 today
- Market cap
- $443.01M
- Beta
- 1.75
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$3.46
Volume 1.09M
Average 0.89M
ARVN Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Arvinas, Inc.NASDAQ: ARVN
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation outflow shrinks to $0
Q1 FY2026 stock-based compensation was $0, compared with $15M a year earlier. Trailing-twelve-month stock-based compensation was $18.8M. Over 3 fiscal years it compounded at -16.5% a year.
Context
- Stock-based compensation amounted to 16.8% of revenue in FY2025, down 16.7 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $4.7M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 44M USD
- Year-over-year change
- -50.1%
- 4-year CAGR
- -6.3%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 44M | -50.1% |
| FY2024 | 2024-12-31 | 88.2M | +23.2% |
| FY2023 | 2023-12-31 | 71.6M | -5.2% |
| FY2022 | 2022-12-31 | 75.5M | +32.2% |
| FY2021 | 2021-12-31 | 57.1M | — |
Stock-Based Compensation vs competitors
How ARVN compares with its peers on the latest reported figures
- ARVN's LTM Mar 2026 stock-based compensation of $18.8M is the 4th largest of the 6 companies compared; the peer median is $19.52M.
- Its year-over-year change of -77.8% is the lowest of 6, against a peer median of +8.7%.
- Stock-based compensation amounts to 21.0% of revenue for ARVN, versus a peer median of 45.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $65.2M | +11.7% | +19.1% | 62.1% | |
| LTM Aug 2026 | $40.66M | +8.7% | +10.5% | 5.8% | |
| LTM Mar 2026 | $19.52M | +5.2% | +17.4% | 45.4% | |
| LTM Mar 2026 | $18.8M | -77.8% | -16.5% | 21.0% | |
| LTM Mar 2026 | $16.26M | -43.8% | -14.0% | 46.7% | |
| LTM Mar 2026 | $7.36M | +42.2% | — | 26.1% | |
| Peer median (excluding ARVN) | $19.52M | +8.7% | +13.9% | 45.4% | |
Competitors are the stored peer set for ARVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (191M) | (282.5M) | (367.3M) | (198.9M) | (80.8M) |
| Depreciation & Amortization | 6M | 8.2M | 6.7M | 6.6M | 5.2M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 57.1M | 75.5M | 71.6M | 88.2M | 44M |
| Change in Working Capital | 678.3M | (82.6M) | (44.4M) | (140.6M) | (233.7M) |
| Accounts Receivables | (30.2M) | 14M | 800K | (5.7M) | 7.3M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 27.9M | 20.2M | 17.3M | (21.2M) | (1.7M) |
| Other Working Capital | 680.6M | (116.8M) | (62.5M) | (113.7M) | (239.3M) |
| Other Non-Cash Items | 9M | 7.9M | (14.4M) | (14.6M) | (8.5M) |
| Operating Cash Flow | 559.4M | (273.5M) | (347.8M) | (259.3M) | (273.8M) |
| Capital Expenditures | (4.7M) | (6.8M) | (2.9M) | (1.8M) | (1.9M) |
| Acquisitions (Net) | 0 | 400K | 0 | 100K | 0 |
| Purchases of Investments | (1.74B) | (886.4M) | (956.3M) | (652.1M) | (354.2M) |
| Sales of Investments | 435.7M | 1.14B | 1.16B | 688.5M | 763.7M |
| Other Investing Activities | 0 | (400K) | 0 | 0 | 0 |
| Investing Cash Flow | (1.31B) | 242.8M | 203.5M | 34.7M | 407.6M |
| Debt Repayment | 0 | 0 | 0 | (400K) | (200K) |
| Common Stock Issued | 264.6M | 4.7M | 387.2M | 8.3M | 700K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (91.9M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 14M | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 278.6M | 4.7M | 374.7M | 7.9M | (91.4M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (475.6M) | (26M) | 230.4M | (216.7M) | 42.4M |
| Free Cash Flow | 554.7M | (280.3M) | (350.7M) | (261.1M) | (275.7M) |
Arvinas, Inc.
NASDAQ:ARVN
Intrinsic Alpha fair value
Locked
Current Price
$6.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.